| Financial Year |
March 31 2023 |
| Monetary Funds |
260,971,622.53 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
47,178,400.49 |
| Accounts Receivable |
547,510,522.68 |
| Advances to Suppliers |
9,643,980.21 |
| Other Receivables |
4,022,513.11 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
355,625,662.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,307,769.97 |
| Total Current Assets |
1,355,969,381.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
192,955,365.56 |
| Under-construction Projects |
38,157,149.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
24,331,868.60 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,355,860.59 |
| Deferred Income Tax Assets |
12,219,660.63 |
| Other Non-Current Assets |
1,150,107.92 |
| Sub-Total of Non-Current Assets |
280,361,815.93 |
| Total Assets |
1,636,331,197.43 |
| Short-Term Loans |
470,340,805.18 |
| Trading Financial liabilities |
-- |
| Notes Payable |
52,687,716.22 |
| Accounts Payable |
28,179,063.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,742,324.90 |
| Taxes Payable |
6,209,678.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
53,120.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,751,561.14 |
| Other Current Liabilities |
2,798,874.43 |
| Sub-Total of Current Liabilities |
596,514,712.23 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,794,166.79 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,708,813.51 |
| Total Liabilities |
606,223,525.74 |
| Paid-In Capital(Or Share Stock) |
332,800,000.00 |
| Capital Surplus |
191,790,942.66 |
| Surplus Reserve |
49,899,369.37 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
445,195,879.57 |
| Minority Stockholder's Interest |
1,253,370.52 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,028,854,301.17 |
| Owner's Equity（Stockholder's Equity） |
1,030,107,671.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,636,331,197.43 |
